News


Voluntary exercise does not appear to alleviate anxiety and depression 

CHICAGO – Voluntary physical activity does not appear to cause a reduction in anxiety and depression, but exercise and mood may be associated through a common genetic factor, according to a report in the August issue of Archives of General Psychiatry, one of the JAMA/Archives journals. 

In the general population, regular exercise is associated with reduced anxious and depressive symptoms, according to background information in the article. Experiments involving specific clinical populations have suggested that exercise causes this reduction in anxiety and depression. However, it is unclear whether this causal effect also occurs in the larger population or whether there is a third underlying factor influencing both physical activity and the risk for mood disorders. 

Marleen H. M. De Moor, M.Sc., of VU University Amsterdam, the Netherlands, and colleagues studied 5,952 twins from the Netherlands Twin Register, along with 1,357 additional siblings and 1,249 parents. Participants, all aged 18 to 50, filled out surveys about leisure-time exercise and completed four scales measuring anxious and depressive symptoms. 

Associations observed between exercise and anxious and depressive symptoms “were small and were best explained by common genetic factors with opposite effects on exercise behavior and symptoms of anxiety and depression,” the authors note. “In genetically identical twin pairs, the twin who exercised more did not display fewer anxious and depressive symptoms than the co-twin who exercised less.” Exercise behavior in one identical twin predicted anxious and depressive symptoms in the other, meaning that if one twin exercised more, the other tended to have fewer symptoms.  

However, the same was not true of dizygotic (fraternal) twins or other siblings, who share only part of their genetic material. In addition, analyses over time showed that individuals who increased their level of exercise did not experience a decrease in anxious and depressive symptoms. 

“It is unknown which genes might be involved in voluntary exercise behavior and in the risk for anxiety and depression,” the authors write, but genes involved in the brain pathways that process dopamine, norepinephrine, opioids or serotonin are likely candidates. 

The results do not mean that exercise cannot benefit those with anxiety or depression, the authors note, only that additional trials would be needed to justify this type of therapy. “Only voluntary leisure-time exercise is influenced by genetic factors, whereas the other type of exercise [directed and monitored by someone else] is environment-driven. The absence of causal effects of voluntary exercise on symptoms of anxiety and depression does not imply that manipulation of exercise cannot be used to change such symptoms,” they write. “The antidepressant effects of exercise may only occur if the exercise is monitored and part of a therapeutic program.” 

Arch Gen Psychiatry. 2008;65[8]:897-905. Available on this website, see 'publications', click 'papers'.

Editor’s Note: This study was supported by grants from the Netherlands Organization for Scientific Research. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

More on this article can be found on these sites:

http://www.medicalnewstoday.com

http://www.medilexicon.com


Subtle differences in DNA of identical twins may help diagnose disease

BIRMINGHAM, Ala. - Identical twins are not completely identical, according to new research from UAB (University of Alabama at Birmingham), jointly with Leiden University Medical Center and VU University, The Netherlands; and Uppsala University and Karolinska Institutet, Sweden. The subtle differences in twin’s DNA may help researchers learn more about a wide range of hereditary diseases and provide a quicker diagnosis for genetic disorders. The findings were published February 14th 2008 in the American Journal of Human Genetics, describing results from an international team led by UAB scientists.

The researchers studied 19 pairs of monozygotic, or identical, twins and found differences in copy number variation in DNA. Copy number variation (CNV) occurs when a set of coding letters in DNA are missing, or when extra copies of segments of DNA are produced.

Humans receive one chromosome from their mother and one from their father, providing for two copies of the genome.  In some cases, bits of DNA are missing from a chromosome, leaving the offspring with just one copy of that bit of DNA. In other instances, mutations may produce three, four or more copies of a particular bit of DNA. In most cases, variation in the number of copies likely has no impact on health or development. But in others, it may be one factor in the likelihood of developing a disease.

“The presumption has always been that identical twins are identical down to their DNA,” said Carl Bruder, Ph.D. and Jan Dumanski, Ph.D., of UAB’s Department of Genetics and the study’s lead authors. “That’s mostly true, but our findings suggest that there are small, subtle differences due to CNV. Those differences may point the way to better understanding of genetic diseases when we study so-called discordant monozygotic twins….a pair of twins where one twin has a disorder and the other does not.”

Bruder points out that one twin might develop a particular disease…Parkinson’s, for example…while the other does not. Previously, it was thought that environmental factors were the likely culprits, not genetics. Bruder and Dumanski think their findings indicate that CNV may play a critical role and this can be efficiently studied in identical twins.

“More importantly, changes in CNV may tell us if a missing gene, or multiple copies of a gene, are implicated in the onset of disease,” Bruder said. “If twin A develops Parkinson’s and twin B does not, the region of their genome where they show differences is a target for further investigation to discover the basic genetic underpinnings of the disease.”

The UAB lab is one of the few worldwide that can make the full genome BAC (bacterial artificial chromosome) arrays that are used to find the changed DNA regions.

The research was funded by support from UAB, the Swedish Cancer Society, the Swedish Children’s Cancer Foundation, the U.S. Army Research and Material Command, National Institutes of Health, The Netherlands Genomics Initiative and the National Institutes of Health. 

www.uab.edu/news